Citadel Advisors’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-26,100
| Closed | -$1.88M | – | 14106 |
|
|
2020
Q4 | $1.88M | Sell |
26,100
-8,600
| -25% | -$450K | ﹤0.01% | 5467 |
|
|
2020
Q3 | $1.58M | Sell |
34,700
-16,000
| -32% | -$669K | ﹤0.01% | 5164 |
|
|
2020
Q2 | $2.29M | Buy |
50,700
+20,300
| +67% | +$910K | ﹤0.01% | 4329 |
|
|
2020
Q1 | $1.17M | Buy |
30,400
+13,600
| +81% | +$626K | ﹤0.01% | 5051 |
|
|
2019
Q4 | $778K | Sell |
16,800
-20,300
| -55% | -$879K | ﹤0.01% | 6053 |
|
|
2019
Q3 | $1.51M | Sell |
37,100
-400
| -1% | -$17.3K | ﹤0.01% | 4919 |
|
|
2019
Q2 | $1.81M | Sell |
37,500
-8,200
| -18% | -$431K | ﹤0.01% | 4693 |
|
|
2019
Q1 | $2.86M | Buy |
45,700
+3,700
| +9% | +$254K | ﹤0.01% | 3846 |
|
|
2018
Q4 | $2.51M | Buy |
42,000
+700
| +2% | +$42K | ﹤0.01% | 3800 |
|
|
2018
Q3 | $2.66M | Sell |
41,300
-1,900
| -4% | -$106K | ﹤0.01% | 3924 |
|
|
2018
Q2 | $1.94M | Buy |
43,200
+11,600
| +37% | +$463K | ﹤0.01% | 4160 |
|
|
2018
Q1 | $981K | Sell |
31,600
-3,100
| -9% | -$102K | ﹤0.01% | 4835 |
|
|
2017
Q4 | $1.04M | Sell |
34,700
-1,600
| -4% | -$46.3K | ﹤0.01% | 4603 |
|
|
2017
Q3 | $1.2M | Buy |
36,300
+2,400
| +7% | +$83.1K | ﹤0.01% | 4057 |
|
|
2017
Q2 | $1.13M | Buy |
33,900
+8,100
| +31% | +$242K | ﹤0.01% | 3910 |
|
|
2017
Q1 | $747K | Sell |
25,800
-1,500
| -5% | -$37.2K | ﹤0.01% | 4438 |
|
|
2016
Q4 | $610K | Buy |
27,300
+12,800
| +88% | +$250K | ﹤0.01% | 4586 |
|
|
2016
Q3 | $269K | Buy |
+14,500
| New | +$273K | ﹤0.01% | 5864 |
|
|
2016
Q2 | – | Sell |
-12,300
| Closed | -$144K | – | 7956 |
|
|
2016
Q1 | $144K | Buy |
12,300
+1,000
| +9% | +$11.2K | ﹤0.01% | 5855 |
|
|
2015
Q4 | $132K | Sell |
11,300
-12,600
| -53% | -$159K | ﹤0.01% | 6380 |
|
|
2015
Q3 | $293K | Buy |
23,900
+15,700
| +191% | +$200K | ﹤0.01% | 5596 |
|
|
2015
Q2 | $77K | Buy |
8,200
+1,800
| +28% | +$16.7K | ﹤0.01% | 7341 |
|
|
2015
Q1 | $57K | Buy |
6,400
+5,300
| +482% | +$53.5K | ﹤0.01% | 7305 |
|
|
2014
Q4 | $11K | Sell |
1,100
-2,700
| -71% | -$23.2K | ﹤0.01% | 8122 |
|
|
2014
Q3 | $25K | Hold |
3,800
| – | – | ﹤0.01% | 7316 |
|
|
2014
Q2 | $27K | Sell |
3,800
-20,100
| -84% | -$160K | ﹤0.01% | 7152 |
|
|
2014
Q1 | $241K | Sell |
23,900
-9,200
| -28% | -$84.7K | ﹤0.01% | 5301 |
|
|
2013
Q4 | $263K | Buy |
33,100
+2,300
| +7% | +$21.5K | ﹤0.01% | 4728 |
|
|
2013
Q3 | $305K | Buy |
30,800
+7,800
| +34% | +$61.4K | ﹤0.01% | 4341 |
|
|
2013
Q2 | $136K | Buy |
+23,000
| New | +$77.4K | ﹤0.01% | 4987 |
|
Other funds holding BEAT
Citadel Advisors's BEAT Position: Q1 2021 in Review
Citadel Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 25,255 shares — an estimated $1.82M sold.
Citadel Advisors first reported a position in BEAT in Q2 2013 and held it in 29 quarters. The position peaked at $6.07M in Q2 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Citadel Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Citadel Advisors sold 25,255 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.82M.
- Citadel Advisors first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 29 quarters.
- Citadel Advisors's BioTelemetry, Inc. position peaked at $6.07M in Q2 2019.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.